We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$4.42B
AUM Growth
+$200M
(+4.7%)
Cap. Flow
+$138M
Cap. Flow
% of AUM
3.13%
Top 10 Holdings %
Top 10 Hldgs %
20.05%
Holding
1,701
New
123
Increased
762
Reduced
644
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
+$34.6M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$24.7M |
| 3 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$22.5M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$15.7M |
| 5 |
SPDR Gold Trust
GLD
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$20.4M |
| 2 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$15.2M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$10.9M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$10.6M |
| 5 |
State Street DoubleLine Total Return Tactical ETF
TOTL
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.64% |
| 2 | Technology | 4.52% |
| 3 | Healthcare | 4.42% |
| 4 | Consumer Staples | 4.24% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADT
726
DELISTED
ADT Corp
ADT
| $701K | 0.02% |
16,992
-2,469
| -13% | -$86.6K |
|
|
MCI
727
Barings Corporate Investors
MCI
$344M
| $698K | 0.02% |
41,029
+4,605
| +13% | +$77.7K |
|
728
iShares International Select Dividend ETF
IDV
$8.53B
| $697K | 0.02% |
24,045
-672
| -3% | -$18.5K |
|
729
TRI-Continental Corp
TY
$1.92B
| $695K | 0.02% |
34,837
+2,085
| +6% | +$39.4K |
|
730
ProShares UltraPro S&P 500
UPRO
$5.86B
| $693K | 0.02% |
+65,700
| New | +$593K |
|
|
HES
731
DELISTED
Hess
HES
| $689K | 0.02% |
13,087
+496
| +4% | +$21.9K |
|
732
Goldman Sachs
GS
$304B
| $686K | 0.02% |
4,372
+629
| +17% | +$97.3K |
|
733
Eastman Chemical
EMN
$8.43B
| $684K | 0.02% |
9,463
+328
| +4% | +$21.5K |
|
734
LyondellBasell Industries
LYB
$20.2B
| $682K | 0.02% |
7,964
+1,660
| +26% | +$133K |
|
735
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.8B
| $682K | 0.02% |
18,088
+1,040
| +6% | +$38.5K |
|
|
MPT
736
Medical Properties Trust
MPT
$2.51B
| $681K | 0.02% |
52,452
+17,272
| +49% | +$197K |
|
|
SVC
737
Service Properties Trust
SVC
$1.06B
| $681K | 0.02% |
5,131
-796
| -13% | -$96.6K |
|
738
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.7B
| $680K | 0.02% |
11,416
-278
| -2% | -$15.8K |
|
739
Bank of Montreal
BMO
$129B
| $679K | 0.02% |
11,192
+909
| +9% | +$49.8K |
|
|
PX
740
DELISTED
Praxair Inc
PX
| $679K | 0.02% |
5,933
-1,998
| -25% | -$209K |
|
|
RESP
741
DELISTED
WisdomTree U.S. ESG Fund
RESP
| $678K | 0.02% |
28,470
-441
| -2% | -$9.91K |
|
|
JE
742
DELISTED
Just Energy Group Inc
JE
| $675K | 0.02% |
3,442
-229
| -6% | -$46.6K |
|
743
iShares US Industrials ETF
IYJ
$1.96B
| $674K | 0.02% |
12,600
-4,360
| -26% | -$217K |
|
744
Pitney Bowes
PBI
$2.28B
| $674K | 0.02% |
31,269
+2,506
| +9% | +$47.6K |
|
745
Carter's
CRI
$1.44B
| $673K | 0.02% |
6,383
+995
| +18% | +$95.4K |
|
|
CBI
746
DELISTED
Chicago Bridge & Iron Nv
CBI
| $673K | 0.02% |
18,397
-1,206
| -6% | -$43.1K |
|
747
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
| $672K | 0.02% |
17,126
-370
| -2% | -$13.4K |
|
|
HQL
748
abrdn Life Sciences Investors
HQL
$643M
| $672K | 0.02% |
37,463
+6,032
| +19% | +$109K |
|
749
Textron
TXT
$15.1B
| $672K | 0.02% |
18,424
-50
| -0.3% | -$1.75K |
|
750
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $672K | 0.02% |
13,009
-532
| -4% | -$27.6K |
|
Similar funds
LP
HF
Cambridge Investment Research Advisors's Q1 2016 Portfolio in Review
As of Q1 2016, Cambridge Investment Research Advisors held 1,701 positions worth $4.42B, up 4.7% from $4.22B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors deployed $138M of net new capital in Q1 2016, opening 123 new positions and adding to 762 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $20.4M trimmed.
- Cambridge Investment Research Advisors's largest Q1 2016 buy was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
- Cambridge Investment Research Advisors added most to DIPLOMAT PHARMACY, INC. in Q1 2016, an estimated $34.6M increase.
- Cambridge Investment Research Advisors's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.4M.
- Cambridge Investment Research Advisors fully exited iShares Currency Hedged MSCI Emerging Markets in Q1 2016, selling an estimated $1.72M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $4.42B portfolio in Q1 2016.
- Cambridge Investment Research Advisors opened 123 new positions and closed 96 in Q1 2016.
- Cambridge Investment Research Advisors's portfolio value rose 4.7% quarter-over-quarter to $4.42B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2016, filed 3 May 2016.